Methylenetetrahydrofolate reductase genotype association with the risk of follicular lymphoma

Cancer Genetics and Cytogenetics

Volumn 195, Issue 2, 2009, Pages 120-124

  Ismail, Said I ^a   Ababneh, Nida A ^a   Khader, Yousef ^b   Abu Khader, Ahmad A ^c   Awidi, Abdullah ^a  

^a Department of Curriculum and Instruction   (Jordan)

^b JORDAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Jordan)

^c HASHEMITE UNIVERSITY   (Jordan)

Author keywords

[No Author keywords available]

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); ALANINE; CYSTEINE; THREONINE;

ARTICLE; CANCER RISK; CANCER SUSCEPTIBILITY; CONTROLLED STUDY; FOLLICULAR LYMPHOMA; GENE FREQUENCY; GENE MUTATION; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENOTYPE; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; HUMAN TISSUE; JORDAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SINGLE NUCLEOTIDE POLYMORPHISM;

BASE SEQUENCE; DNA METHYLATION; DNA PRIMERS; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; LYMPHOMA, FOLLICULAR; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); POLYMERASE CHAIN REACTION;

EID: 70949098205     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cancergencyto.2009.06.026     Document Type: Article

References (32)

1. Ueland P.M., Hustad S., Schneede J., Refsum H., and Vollset S.E. Biological and clinical implications of the MTHFR C677T polymorphism. Trends Pharmacol Sci 22 (2001) 195-201
2. Botto L.D., and Yang Q. 5,10-Methylenetetrahydrofolate reductase gene variants and congenital anomalies: a HuGE review. Am J Epidemiol 151 (2000) 862-877
3. Robien K., and Ulrich C.M. 5,10-Methylenetetrahydrofolate reductase polymorphisms and leukemia risk: a HuGE minireview. Am J Epidemiol 157 (2003) 571-582
4. Frosst P., Blom H.J., Milos R., Goyette P., Sheppard C.A., Matthews R.G., Boers G.J., den Heijer M., Kluijtmans L.A., van den Heuvel L.P., and Rozen R. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet 10 (1995) 111-113
5. Van der Put N.M., Gabreëls F., Stevens E.M., Smeitink J.A., Trijbels F.J., Eskes T.K., van den Heuvel L.P., and Blom H.J. A second common mutation in the methylenetetrahydrofolate reductase gene: an additional risk factor for neural-tube defects?. Am J Hum Genet 62 (1998) 1044-1051
6. Weisberg I., Tran P., Christensen B., Sibani S., and Rozen R. A second genetic polymorphism in methylenetetrahydrofolate reductase (MTHFR) associated with decreased enzyme activity. Mol Genet Metab 64 (1998) 169-172
7. Duthie S.J., and McMillan P. Uracil misincorporation in human DNA detected using single cell gel electrophoresis. Carcinogenesis 18 (1997) 1709-1714
8. Blount B.C., Mack M.M., Wehr C.M., MacGregor J.T., Hiatt R.A., Wang G., Wickramasinghe S.N., Everson R.B., and Ames B.N. Folate deficiency causes uracil misincorporation into human DNA and chromosome breakage: implications for cancer and neuronal damage. Proc Natl Acad Sci U S A 94 (1997) 3290-3295
9. Robien K., Ulrich C.M., Bigler J., Yasui Y., Gooley T., Bruemmer B., Potter J.D., and Radich J.P. Methylenetetrahydrofolate reductase genotype affects risk of relapse after hematopoietic cell transplantation for chronic myelogenous leukemia. Clin Cancer Res 10 (2004) 7592-7598
10. Hur M., Park J.Y., Cho H.C., Lee K.M., Shin H.Y., and Cho H.I. Methylenetetrahydrofolate reductase A1298C genotypes are associated with the risks of acute lymphoblastic leukaemia and chronic myelogenous leukaemia in the Korean population. Clin Lab Haematol 28 (2006) 154-159
11. Yi P., and Pogribny I. Jill James S. Multiplex PCR for simultaneous detection of 677 C→T and 1298 A→C polymorphisms in methylenetetrahydrofolate reductase gene for population studies of cancer risk. Cancer Lett 26 (2002) 181-209
12. Slattery M.L., Potter J.D., Samowitz W., Schaffer D., and Leppert M. Methylenetetrahydrofolate reductase, diet, and risk of colon cancer. Cancer Epidemiol Biomarkers Prev 8 (1999) 513-518
13. Shen H., Xu Y., Zheng Y., Qian Y., Yu R., Qin Y., Wang X., Spitz M.R., and Wei Q. Polymorphisms of the 5,10-methylenetetrahydrofolate reductase and risk of gastric cancer in a Chinese population: a case-control study. Int J Cancer 9 (2001) 332-336
14. Song C., Xing D., Tan W., Wei Q., and Lin D. Methylenetetrahydrofolate reductase polymorphisms increase risk of esophageal squamous cell carcinoma in a Chinese population. Cancer Res 61 (2001) 3272-3275
15. Piyathilake C.J., Macaluso M., Johanning G.L., Whiteside M., Heimburger D.C., and Giuliano A. Methylenetetrahydrofolate reductase (MTHFR) polymorphism increases the risk of cervical intraepithelial neoplasia. Anticancer Res 20 (2000) 1751-1757
16. Alcasabas P., Ravindranath Y., Goyette G., Haller A., Del Rosario L., Lesaca-Medina M.Y., Darga L., Ostrea Jr. E.M., Taub J.W., and Everson R.B. 5,10-methylenetetrahydrofolate reductase (MTHFR) polymorphisms and the risk of acute lymphoblastic leukemia (ALL) in Filipino children. Pediatr Blood Cancer 51 (2008) 178-182
17. Kim N.K., Chong S.Y., Jang M.J., Hong S.H., Kim H.S., Cho E.K., Lee J.A., Ahn M.J., Kim C.S., and Oh D. Association of the methylenetetrahydrofolate reductase polymorphism in Korean patients with childhood acute lymphoblastic leukemia. Anticancer Res 26 (2006) 2879-2881
18. Reddy H., and Jamil K. Polymorphisms in the MTHFR gene and their possible association with susceptibility to childhood acute lymphocytic leukemia in an Indian population. Leuk Lymphoma 47 (2006) 1333-1339
19. Skibola C.F., Smith M.T., Kane E., Roman E., Rollinson S., Cartwright R.A., and Morgan G. Polymorphisms in the methylenetetrahydrofolate reductase gene are associated with susceptibility to acute leukemia in adults. Proc Natl Acad Sci U S A 96 (1999) 12810-12815
20. Krajinovic M., Lamothe S., Labuda D., Lemieux-Blanchard E., Theoret Y., Moghrabi A., and Sinnett D. Role of MTHFR genetic polymorphisms in the susceptibility to childhood acute lymphoblastic leukemia. Blood 103 (2004) 252-257
21. Da Costa Ramos F.J., Cartaxo Muniz M.T., Silva V.C., Araújo M., Leite E.P., Freitas E.M., Zanrosso C.W., Hatagima A., de Mello M.P., Yunes J.A., Marques-Salles Tde J., Santos N., Brandalise S.R., and Pombo-De-Oliveira M.S. Association between the MTHFR A1298C polymorphism and increased risk of acute myeloid leukemia in Brazilian children. Leuk Lymphoma 47 (2006) 2070-2075
22. Moon H.W., Kim T.Y., Oh B.R., Min H.C., Cho H.I., Bang S.M., Lee J.H., Yoon S.S., and Lee D.S. MTHFR 677CC/1298CC genotypes are highly associated with chronic myelogenous leukemia: a case-control study in Korea. Leuk Res 31 (2007) 1213-1217
23. Rudd M.F., Sellick G.S., Allinson R., Matutes E., Catovsky D., and Houlston R.S. MTHFR polymorphisms and risk of chronic lymphocytic leukemia. Cancer Epidemiol Biomarkers Prev 13 (2004) 2268-2270
24. Matsuo K., Hamajima N., Suzuki R., Ogura M., Kagami Y., Taji H., Yasue T., Mueller N.E., Nakamura S., Seto M., Morishima Y., and Tajima K. Methylenetetrahydrofolate reductase gene (MTHFR) polymorphisms and reduced risk of malignant lymphoma. Am J Hematol 77 (2004) 351-357
25. Siraj A.K., Ibrahim M., Al-Rasheed M., Bu R., Bavi P., Jehan Z., Abubaker J., Murad W., Al-Dayel F., Ezzat A., El-Solh H., Uddin S., and Al-Kuraya K. Genetic polymorphisms of methylenetetrahydrofolate reductase and promoter methylation of MGMT and FHIT genes in diffuse large B cell lymphoma risk in Middle East. Ann Hematol 86 (2007) 887-895
26. Habib E.E., Aziz M., and Kotb M. Genetic polymorphism of folate and methionine metabolizing enzymes and their susceptibility to malignant lymphoma. J Egypt Natl Canc Inst 17 (2005) 184-192
27. Niclot S., Pruvot Q., Besson C., Savoy D., Macintyre E., Salles G., Brousse N., Varet B., Landais P., Taupin P., Junien C., and Baudry-Bluteau D. Implication of the folate-methionine metabolism pathways in susceptibility to follicular lymphoma. Blood 108 (2006) 278-285
28. Lee K.M., Lan Q., Kricker A., Purdue M.P., Grulich A.E., Vajdic C.M., Turner J., Whitby D., Kang D., Chanock S., Rothman N., and Armstrong B.K. One-carbon metabolism gene polymorphisms and risk of non-Hodgkin lymphoma in Australia. Hum Genet 122 (2007) 525-533
29. Gemmati D., Ongaro A., Scapoli G.L., Della Porta M., Tognazzo S., Serino M.L., Di Bona E., Rodeghiero F., Gilli G., Reverberi R., Caruso A., Pasello M., Pellati A., and De Mattei M. Common gene polymorphisms in the metabolic folate and methylation pathway and the risk of acute lymphoblastic leukemia and non-Hodgkin's lymphoma in adults. Cancer Epidemiol Biomarkers Prev 13 (2004) 787-794
30. Kim H.N., Lee I.K., Kim Y.K., Tran H.T., Yang D.H., Lee J.J., Shin M.H., Park K.S., Shin M.G., Choi J.S., and Kim H.J. Association between folate-metabolizing pathway polymorphism and non-Hodgkin lymphoma. Br J Haematol 140 (2008) 287-294
31. Crott J.W., Mashiyama S.T., Ames B.N., and Fenech M.F. Methylenetetrahydrofolate reductase C677T polymorphism does not alter folic acid deficiency-induced uracil incorporation into primary human lymphocyte DNA in vitro. Carcinogenesis 22 (2001) 1019-1025
32. Crott J.W., Mashiyama S.T., Ames B.N., and Fenech M. The effect of folic acid deficiency and MTHFR C677T polymorphism on chromosome damage in human lymphocytes in vitro. Cancer Epidemiol Biomarkers Prev 10 (2001) 1089-1096